We specifically found that higher CSF α-synuclein levels were linked to Aβ pathology in APOE ε4-carrying subjects with asymptomatic familial AD [45], and to disease progression in sporadic AD patients examined in the current study. The gene discussed is APOE; the disease is Alzheimer disease.